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Abstract
Clostridium difficile infection (CDI) is an important cause of mortality and morbidity in healthcare settings. The major
virulence determinants are large clostridial toxins, toxin A (tcdA) and toxin B (tcdB), encoded within the pathogenicity locus
(PaLoc). Isolates vary in pathogenicity from hypervirulent PCR-ribotypes 027 and 078 with high mortality, to benign non-
toxigenic strains carried asymptomatically. The relative pathogenicity of most toxigenic genotypes is still unclear, but may
be influenced by PaLoc genetic variant. This is the largest study of C. difficile molecular epidemiology performed to date, in
which a representative collection of recent isolates (n = 1290) from patients with CDI in Oxfordshire, UK, was genotyped by
multilocus sequence typing. The population structure was described using NeighborNet and ClonalFrame. Sequence
variation within toxin B (tcdB) and its negative regulator (tcdC), was mapped onto the population structure. The 69
Sequence Types (ST) showed evidence for homologous recombination with an effect on genetic diversification four times
lower than mutation. Five previously recognised genetic groups or clades persisted, designated 1 to 5, each having a
strikingly congruent association with tcdB and tcdC variants. Hypervirulent ST-11 (078) was the only member of clade 5,
which was divergent from the other four clades within the MLST loci. However, it was closely related to the other clades
within the tcdB and tcdC loci. ST-11 (078) may represent a divergent formerly non-toxigenic strain that acquired the PaLoc
(at least) by genetic recombination. This study focused on human clinical isolates collected from a single geographic
location, to achieve a uniquely high density of sampling. It sets a baseline of MLST data for future comparative studies
investigating genotype virulence potential (using clinical severity data for these isolates), possible reservoirs of human CDI,
and the evolutionary origins of hypervirulent strains.
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Introduction
Clostridium difficile infection (CDI) is a major concern in
healthcare settings worldwide. Symptoms range from mild
diarrhoea to life threatening pseudomembranous colitis, with 6%
mortality overall, rising to 13.5% in older patients [1]. Individuals
may be asymptomatically colonised in the community, or acquire
the bacteria nosocomially [2]. Risk factors predisposing colonised
patients to develop symptoms include antibiotic treatment and
advanced age [3–5].
The major C. difficile virulence factors are large clostridial toxins
designated toxin A (TcdA) and toxin B (TcdB). TcdA and TcdB
share 63% amino acid sequence similarity [6] and four functional
domains; a N-terminal catalytic domain, an autocatalytic cysteine
protease, a hydrophobic membrane translocation domain and a C-
terminal receptor binding domain (RBD) [7,8]. Evidence that TcdB
alone is essential for virulence has been provided [9], however, more
recent data indicate that both toxins are important [10]. TcdA and
TcdB are encoded within the 19.6kb pathogenicity locus (PaLoc),
together with three additional genes; tcdC, tcdR and tcdE. PaLoc gene
expression is growth phase dependent. During early logarithmic
growth, high levels of tcdC and low levels of tcdA, tcdB, and tcdR are
transcribed; during stationary phase the converse is true [11–13]. It
is therefore thought that TcdC and TcdR are negative and positive
regulators, respectively, of toxin expression [11,14].
The molecular epidemiology of C. difficile has been studied using
many different genotyping methods [15–17]. This led to the
identification of epidemic and hypervirulent genotypes associated
with increased morbidity and mortality. One such strain emerged
in 2000–2001 [18] causing large CDI outbreaks with high
mortality [19–21]. This strain is designated BI by restriction
endonuclease typing (REA), NAP1 by pulsed field gel electropho-
resis (PFGE), ST-1 by multilocus sequence typing (MLST) and 027
by PCR-ribotyping [18,19,21,22]. The production of toxin in vitro
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by PCR-ribotype 027 has been described as robust, but not
significantly different to non-hypervirulent strains [23], and as 16
to 23-fold higher than non-epidemic strains [24]. In a human gut
model that simulates CDI, the duration of cytotoxin production by
PCR-ribotype 027 was markedly longer than that of PCR-ribotype
001 (23 versus 13 days), and was associated with increased
prevalence of vegetative cells, but peak toxin titres were similar
[25]. PCR-ribotype 027 also shows increased sporulation efficien-
cy [23,26].
PCR-ribotype 078 has also been described as hypervirulent
since it can cause symptoms of similar severity to 027 [27]. This
PCR-ribotype produces less TcdA and TcdB in vitro than 027, but
more than other toxinotypes [28]. PCR-ribotype 078 is frequently
isolated from livestock [28] and its incidence in human disease
appears to be increasing [17,29].
Two characteristics of the PCR-ribotype 027 PaLoc have been
proposed to explain its virulence. Firstly, the 027-tcdB-RBD is
genetically divergent from other strains, apparently conferring
broader cell tropism and more rapid cell entry [30–32]. Secondly,
the tcdC gene has a single nucleotide deletion causing a frameshift
that truncates the protein. This has been postulated to remove log
phase repression of toxin expression [18,24,33,34]. PCR-ribotype
078 also encodes a truncated TcdC [34], caused by a single
nucleotide substitution creating a stop codon. The precise
frequency and distribution of these potential hypervirulence-
promoting PaLoc variants within the C. difficile population
structure is unclear. This is due to the lack of recent large scale
studies assessing simultaneously the clinical C. difficile population
structure, and the nucleotide sequences of PaLoc variants.
The C. difficile population structure is clonal [22,35,36],
comprising five genetic groups or clades [22] which persist despite
homologous recombination [37]. Existing data suggest a congru-
ent relationship between tcdC variant and genotype [34,36,38],
and possibly a similar relationship for TcdB-RBD, although these
data are more limited [36]. Many genotypes, representing all five
clades [22] are currently associated with CDI [17,22,29,39], and
data on their relative pathogenicity would assist patient manage-
ment and infection control. In particular, the incidence of PCR-
ribotype 027 has declined recently in many countries, and the
virulence potential of the now endemic PCR-ribotype 027 relative
to other endemic genotypes is less clear [5,40].
Our aims were to define the TcdB-RBD and TcdC variants for
1290 recent clinical isolates collected from a large, contempora-
neous cohort of consecutive CDI cases, and determine their
relationship to the C. difficile population structure defined by
MLST. This would facilitate study of the evolutionary mechanisms
among C. difficile isolates representing a clearly defined collection
of co-circulating strains, as well as the estimation of genotype
pathogenic potential based on PaLoc tcdB-RBD and tcdC similarity
to known hypervirulent genotypes. The size of the study and
density of sampling in a single geographic location provides a
baseline of C. difficile MLST data. C. difficile genotypes can vary
with host species, geographic location and over time, [41–43]. Our
data set, together with the inherent inter-laboratory comparability
and portability of all MLST data, (http://pubmlst.org/cdifficile)
will help facilitate comparative studies to understand the reservoirs
of human CDI, its international transmission and the evolutionary
origin of hypervirulent strains.
Results
C. difficile has a clonal population structure
A total of 69 STs were identified among the 1290 clinical
isolates, 36 of which are described for the first time in this study.
The relative abundance of the STs is summarised in Table 1, with
additional details on the frequency of tcdB-RBD and tcdC alleles in
Table S1. PCR-ribotype data representing each ST are presented
in Table 1, Table S3 and Fig. S1 to contextualise the study. Eight
additional STs were described previously (ST-20, ST-27, ST-29,
ST-32, ST-38, ST-39, ST-40, ST-69) [22], and one (ST-30) was
identified in a separate study of infants (data not shown). All 78
STs were included in the analysis of C. difficile population structure.
The total number of variable nucleotide sites was 127/3501
(3.6%), and amino acids 30/1167 (2.6%). The MLST loci were
under strong conservative selection (dN/dS ,1, Table S2) as
expected for housekeeping genes. The sequences of each ST were
concatenated and analysed using Neighbour-Net [44]. Five clades
of closely related isolates were identified, representing deep
branches of the phylogenetic tree (Fig. 1A). These clades were
described previously [22], and although 36 new STs were
identified in this study, they all fell within one of the five clades.
The relative positions of the hypervirulent ST-1 (027) in clade 2
and ST-11 (078) in clade 5 are shown in Fig. 1A. Extensive
networks were found in the ancestry of clade 1 (Fig. 1A), which
suggest either homologous recombination or a lack of information
to resolve these branchings. The relationships among the STs on
the basis of allelic profile is shown by eBURST [45] (Fig. 1B). This
analysis did not indicate the presence of many discrete clonal
complexes not apparent by nucleotide sequence-based methods.
The five clades were also reconstructed by ClonalFrame [46],
which accounts for the effect of recombination when reconstruct-
ing the genealogy (Fig. 1C). ClonalFrame was used to infer the
numbers of point mutation and homologous recombination events
in the C. difficile population. Recombination occurred approxi-
mately ten times less often than mutation (r/h= 0.08 with
credibility interval [0.04;0.13]), and introduced approximately
four times fewer substitutions than mutation (r/m = 0.25 with
credibility interval [0.12;0.42]).
Detection of the Pathogenicity Locus
The PaLoc was detected by PCR using oligonucleotide primers
which amplify the tcdB-RBD and tcdC loci (Fig. 2A). Absence of the
PaLoc was confirmed using the lok1/lok3 primer pair which bind
chromosomal DNA either side of the ,19.6kb PaLoc (Fig. 2A)
[47]. The lok1/3 PCR amplifies 769 bp in the absence of the
PaLoc, and thus identifies non-toxigenic isolates. A negative lok1/
3 PCR in combination with positive tcdB-RBD and tcdC PCRs
confirmed an isolate was toxigenic. A positive lok1/3 PCR and
negative tcdB-RBD and tcdC PCRs indicated an isolate was non-
toxigenic. All isolates conformed to either of these two patterns
confirming that the PaLoc was present only in the previously
described genomic location [47].
A total of 18 non-toxigenic isolates with seven STs were
identified. Some STs had both toxigenic and non-toxigenic isolates
(ST-3, ST-7 and ST-48), others were non-toxigenic only (ST-15,
ST-23, ST-26, ST-30) (Table 1). Non-toxigenic strains appear not
to represent a separate clade, since five were distributed
throughout clade 1, (ST-3, ST-7, ST-48, ST-15, and ST-26) and
two occurred in clade 4 (ST-23, ST-30) (Fig. 1).
Genetic variation within the tcdB-RBD
The PaLoc position of the tcdB gene, its functional domains and
the region sequenced are summarised in Fig. 2A and B. tcdB-RBD
sequences (597nt) were determined for all isolates. A total of 17
different alleles were identified. Each was assigned a number in the
order of discovery and the sequences made available at http://
pubmlst.org/cdifficile. The association of tcdB-RBD alleles and
clades was congruent (Fig. 3A).
C. difficile: Clonality and PaLoc Diversity
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Clade 1 was most heterogeneous in terms of the number of STs
(n = 65) (Fig. 1), but it was relatively homogenous within the tcdB-
RBD, with nine alleles sharing 98.2% nucleotide and 97.5%
amino acid identity (Fig. 3A and B). Clades 3, 4 and 5 each had a
single clade-specific tcdB-RBD allele. The clade 4 tcdB-RBD9, was
located among the clade 1 variants (Fig. 3A), differing by a single
amino acid from its closest relative (Fig. 3B), an observation
suggestive of recombination. Clades 3 and 5 tcdB-RBDs were
closely related, sharing 97.7% nucleotide and 97.0% amino acid
identity (Fig. 3A and B).
Clade 2 (containing ST-1 [027]) was most heterogeneous in
terms of its tcdB-RBD alleles (Fig. 3A), the five tcdB-RBD alleles
occurring in various combinations with four STs (Table 1); ST-1
(027), ST-41, ST-67, and one ST published previously ST-32 [22].
All ST-1 (027) isolates (n = 448) contained the expected divergent
tcdB-RBD8 sequence [30,31], which clusters with clade 2-
associated tcdB-RBD13 and tcdB-RBD15 (Fig. 3A). Two clade 2
alleles (tcdB-RBD10 and 16) were located on a separate branch of
the neighbour joining tree (Fig. 3A). They appear to have a
complex admixed ancestry, with some polymorphism typical of
Table 1. Frequency of STs (n = 69) within the clinical isolate collection (n = 1290).
ST (n) Clade tcdC Ribotype1 ST (n) Clade tcdC Ribotype1
1 (448) 2 D1stop 027 48 (3) 1 WT 038, 104
2 (86) 1 WT 020, 014, 076, 220 56 (3) 1 WT 021
8 (86) 1 WT 002 72 (3) 1 WT 005
42 (68) 1 WT 106, 174 28 (2) 1 WT 020
6 (59) 1 WT 005 51 (2) 1 WT, D18 186, 249
3 (54) 1 WT 001, 009, 072, 115, 262, 305 57 (2) 1 WT 003
44 (46) 1 WT 015 75 (2) 1 WT 062
5 (43) 3 TAAstop 023 77 (2) 1 WT 011
10 (43) 1 WT, D18 015 19 (1) 1 WT 110
14 (28) 1 WT 014 21 (1) 1 WT 097
11 (27) 5 TAAstop 078 23 (1) 4 N/A 138
9 (22) 1 WT, D18 081 24 (1) 1 WT 202
7 (20) 1 WT 026 25 (1) 3 TAAstop 023
37 (19) 4 WT 017 26 (1) 1 N/A 140
17 (18) 1 WT 018 31 (1) 1 WT 323
58 (18) 1 WT 056 34 (1) 1 WT 056
49 (17) 1 WT 014 50 (1) 1 WT 014
16 (14) 1 WT 050 52 (1) 1 WT 139
13 (12) 1 WT 129 59 (1) 1 WT 316
54 (12) 1 WT 012 60 (1) 1 WT 336
33 (11) 1 WT 216 65 (1) 1 WT 224
36 (11) 1 WT 011 66 (1) 1 WT 022
45 (11) 1 WT 013 67 (1) 2 WT 019
18 (10) 1 WT 050 68 (1) 1 WT 020
12 (8) 1 WT 003, 225 70 (1) 1 WT 021
55 (8) 1 WT 070 71 (1) 1 WT 013
35 (7) 1 WT 046 73 (1) 1 WT 103
53 (7) 1 WT 103 74 (1) 1 WT 319
15 (6) 1 N/A 070 76 (1) 1 WT 103
43 (6) 1 WT 054 78 (1) 1 WT 013
22 (5) 3 TAAstop 023 89 (1) 1 WT 005
63 (5) 1 WT 053 90 (1) 1 WT 005
46 (4) 1 WT 320 91 (1) 1 WT 326
4 (3) 1 WT 137 92 (1) 1 WT 228
41 (3) 2 D18, D1stop 106, 194, 321
STs are ranked in descending order of abundance. The clade that each ST belongs to is indicated, followed by the associated tcdC allele variant(s) classified as WT (wild
type), D18 (having an 18 nt deletion in the coiled coil domain), and D1stop or TAAstop to indicate truncated variants. N/A: not applicable as all isolates of this ST were
non-toxigenic. A more detailed version of this table is also provided as Table S1, to show the frequency of the tcdB-RBD and tcdC alleles associated with each ST.
1PCR-ribotypes found in association with each ST. An ST can have more than one ribotype, however, the converse is also true and this, together with the numbers of
isolates that were PCR-ribotyped is shown in Table S2 and Fig. S1.
doi:10.1371/journal.pone.0019993.t001
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clade 2 and clade 3 tcdB-RBD sequences, as well as a number of
polymorphisms unique to these two alleles (Fig. 3B).
Genetic variation within the tcdC negative regulator
The PaLoc location of the tcdC gene is shown in Fig. 2A and C.
tcdC sequence data (552nt) from the initiation codon to codon 184
of the 233 amino acid protein were determined for all isolates.
This sequence spans all previously described truncations and
deletions within the dimerization domain [14,33,34]. A total of
26 different alleles were identified (Fig. 4). Each allele was
assigned a number in the order of discovery and the sequences
were made available at http://pubmlst.org/cdifficile. The 26
different tcdC variants included nine of 15 tcdC alleles described
previously [34] and a further 17 alleles unique to the present
study. The relationship between the tcdC alleles and the five
clades identified in this population was examined using a
neighbour joining tree. A mostly congruent association was
demonstrated, the one exception being allele tcdC-12 which is
found in ST-3 (clade 1), but has a sequence similar to the tcdC of
clade 2 (Fig. 4A).
The tcdC variants were categorised and named as follows
(Fig. 4B); (i) wild type (WT), (ii) modified by an 18 nucleotide
deletion within the coiled-coil domain, (D18) and (iii) truncated,
either by a single nucleotide deletion causing a frameshift and stop
codon at position 66, (D1stop), or by a single nucleotide
substitution creating a stop codon at position 62 (TAAstop).
All of the tcdC alleles in clades 1 and 4 isolates were wild type,
lacking premature termination codons. However, two clade 1
alleles contained an 18 nucleotide dimerization domain deletion
(Fig. 4). Both were derived from the most abundant tcdC-RBD
allele, (WTtcdC-3), but had different 18 nucleotide deletions
(Fig. 4, Table 1).
The nucleotide locations of all six D18 sequences identified
(Fig. 4) were difficult to define precisely because they occur within
repetitive sequences and more than one equally likely sequence
alignment could be generated. However, ClustalW2 alignments
Figure 1. The C. difficile population is comprised of five clades with evidence of recombination within and among groups. (A)
Phylogenetic network to illustrate relationships among 78 STs comprising the five clades. The networks were constructed using concatenated MLST
loci and the program Neighbour-Net [44]. The clades containing well characterised isolates or genotypes, their ribotypes and STs are indicated (ST-89
was excluded as it differs from ST-6 by a single nucleotide deletion in the sodA locus only). (B) eBURST diagram to show the relationships among STs
based on alleleic profiles [45]. Circle size for each of the 69 STs identified in the clinical isolate collection (total n = 1290) is proportional to the number
of isolates. For completeness, one example of eight additional previously described STs (ST-20, ST-27, ST-29, ST-32, ST-38, ST-39, ST-40, ST-69) [22],
and one (ST-30) identified in a separate study of infants were included to demonstrate their relationship to other members of the population. Well
characterised representatives of each clade are indicated as in (A). STs identified in both toxigenic and non-toxigenic form are indicated by a star. (C)
ClonalFrame analysis [46]. The five clades are indicated and branch lengths are measured in expected number of mutation and recombination events.
doi:10.1371/journal.pone.0019993.g001
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Figure 2. Relative positions of the tcdB and tcdC genes within the PaLoc and the sequences determined in this study. (A) Organisation
of the five genes encoded by the 19.6 kb PaLoc of C. difficile, and two flanking genes containing the lok1/3 primer pair [47]. (B) The four functional
domains of the 2366 amino acid TcdB protein, [7]. The region of the receptor binding domain (RBD) sequenced is indicated (horizontal black bar). The
sequence determined is located within the C-terminal repetitive region which may bind to enteric cells via carbohydrate receptors [60]. (C) The 233
amino acid negative regulator TcdC. The location of the coiled-coil dimerization domain [14] is indicated; deletions found within the repetitive
sequences of this domain are indicated by a triangle. The truncations found in PCR-ribotype 027 and 078 strains are indicated by a vertical bar. The
sequence determined is indicated by a black horizontal bar.
doi:10.1371/journal.pone.0019993.g002
Figure 3. The association of tcdB-RBD alleles and clade is congruent. (A) Neighbour joining tree showing the relationships among the 17
tcdB allele sequences (597nt) and C. sordelii constructed using MEGA with bootstraps calculated using 1000 replicates. Coloured shapes indicate the
clade (Fig. 1) with which each tcdB allele is associated. The number of variable nucleotide sites (excluding C. sordelii) was 97/597 (16.2%) and amino
acids 42/199 (21.1%). * Indicates putative recombinants derived from clade 2 and clade 3 sequences. C. sordelii was used to root the tree as it encodes
the closest known relative to C. difficile tcdB. (B) Alignment of the tcdB-RBD allele variable amino acid sites, relative to the sequence of the CD630
genome strain [51] (clade 1, allele tcdB-2). Alleles tcdB-3, tcdB-4, tcdB-6, and tcdB-17 are not shown as they have an amino acid sequence identical to
tcdB-2. The bold box indicates the closely related sequences of clade 3 and clade 5; the yellow shaded box indicates putative clade 2/clade 3 tcdB
recombinants; * in (A).
doi:10.1371/journal.pone.0019993.g003
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showed that D18TcdC-25 was unique in having its D18 displaced
by 9 nt relative to the other D18 containing alleles (alignment not
shown).
Truncation of the TcdC protein relatively close to the N-terminus
occurred in all clade 3 isolates, by the same nucleotide substitution
(TAAstop) as seen in ST-11 (078), the only member of clade 5. This
truncation was unique to clade 3 and ST-11 (078), which had closely
related tcdC genes (Fig. 4A). Clade 3 and ST-11 (078) also had
deletions within the untranslated nucleotide sequences of the coiled-
coil domain (Fig. 4B); D18 and D54 in clade 3, and D36 in ST-11
(078). The similarity between ST-11 (078) and clade 3 within the
two PaLoc loci sequenced (Fig. 3 and Fig. 4) was surprising, given
the high divergence of the ST-11 (078) MLST loci from other
known genotypes (Fig. 1). It raises the possibility that the ST-11
(078) PaLoc at least, was acquired by homologous recombination.
Clade 2 (containing ST-1 [027]), was the only clade to contain
tcdC variants from all three categories; WT, D18, and D1stop
(Fig. 4) and was therefore unusual in its heterogeneity with regard
to this characteristic. However, all 448 ST-1 (027) isolates
contained allele D1stoptcdC-1, encoding a truncated TcdC
protein.
Almost all STs occurred with a single tcdB-RBD and tcdC
variant; only a few had low frequency variants (Table 1). The two
PaLoc loci did have higher dN/dS values than the housekeeping
loci, but this was still much less than 1, and therefore not indicative
of diversifying selection (Table S2). Overall, tcdB-RBD and tcdC
variants were highly predictive of clade, and in clade 4 and clade 5
also predictive of ST.
Discussion
The population structure of a large (n = 1290), recent collection
of clinical C. difficile isolates, representing a population unit of
circulating strains, was defined using MLST. The sequences of two
loci (PaLoc tcdB-RBD and tcdC) putatively linked to hypervirulence
[18,24,30,31,33,34] were determined, mapped onto the popula-
tion structure, and used to examine the underlying evolutionary
mechanisms.
Figure 4. The association of tcdC alleles and clade is almost congruent. (A) Neighbour joining tree showing the relationship among tcdC
variants and the clades. The variants were manually aligned in BioEdit and a neighbour joining tree was computed using MEGA with bootstraps
calculated using 1000 replicates. Coloured shapes indicate the clade (Fig. 1) with which the tcdC allele was associated. Alleles appear the same if they
differ only in terms of their relative deletion lengths which are indicated in (B). AllelesWTtcdC-8 andWTtcdC-14 appear the same on the tree as they
differ by a single nucleotide at position 117, which is deleted in some other alleles and therefore contained an N in some variants in the alignment. (B)
Predicted translation products from tcdC variants. Three different TcdC variants were found (i) wild type (WT) (ii) truncated by D1 at nucleotide 117
creating a frameshift and a stop codon at amino acid 66, (D1stop), or by a CAA to TAA substitution creating a stop codon at amino acid 62,
(TAAstop) (iii) 18 nucleotides deleted (D18) within the coiled-coil dimerization domain. Further deletions within the untranslated sequence of clade
3 and clade 5 were 36 nucleotides long (D36) or 54 nucleotides long (D54). Translated regions are represented in the figure by the bold black line;
untranslated regions are represented by the light black line.
doi:10.1371/journal.pone.0019993.g004
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Our data confirm the clonal population structure of C. difficile
[22,35,36] and demonstrate a largely congruent association
between clade and PaLoc tcdB-RBD and tcdC variants. Only
occasional deviations from congruence were identified due to
recombination events. STs sharing the same PCR-ribotype were in
most cases closely related (supported by bootstraps, Fig. S1 and
Table S3), further supporting the clonal population structure.
These observations are in agreement with previous suggestions
based on nucleotide sequences [34,36,38], toxinotyping (a RFLP-
PCR based method in which two PCR amplified fragments from
the tcdB and tcdA genes undergo restriction digest to give
characteristic banding patterns) and PCR-ribotyping [48,49].
However, since MLST data allow the precise phylogenetic
relationships among genotypes to be visualised (Fig. 1) the present
study demonstrates that specific PaLoc variants (Fig. 4) are clade-
associated. The ability to cluster genetically related isolates may
provide greater power in future studies aiming to investigate
associations between clinical disease severity and genotype.
The five clades defined by traditional phylogenetic approaches
(Fig. 1A, 1B and [22]) were supported by ClonalFrame analysis
(Fig. 1C, Fig. S1). ClonalFrame showed that recombination had
an effect approximately four times lower than point mutation (r/
m = 0.25 with credibility interval [0.12;0.42]). This is consistent
with a previous estimate of r/m = 0.2, [50] also based on MLST
data [35]. A significantly higher value of r/m between 0.63 and
1.13 has also been reported in the deep phylogeny of C. difficile
based on whole genomes [37]. The authors suggested that this
difference may reflect recombination rates that are lower in
housekeeping genes than the genome as a whole.
Although clade 1 contained by far the highest number of STs,
further work studying additional isolates from diverse sources may
identify additional genotypes within the other clades. STs
submitted by other laboratories to the MLST database (http://
pubmlst.org/cdifficile) suggest this is the case, the exception
currently being clade 5, containing only ST-11 (078). The high
frequency and large number of different clade 1 genotypes
(Table 1) implies that this clade may be particularly well adapted
to humans, and therefore potentially sampled most frequently.
All isolates were cultured from ELISA positive stools (indicating
the presence of toxin A and, or toxin B) and screened for the PaLoc
by lok 1/3 PCR [47]. Eighteen non-toxigenic isolates were
identified suggesting either simultaneous colonisation with a
toxigenic strain, or an unreliable false positive ELISA test result,
which may occur in as many as 20% of cases. All isolates that
contained the Paloc genes tcdB and tcdC were negative for the lok1/3
PCR [47], indicating that despite the high mobility of the C. difficile
genome [51], the PaLoc (in this clinical isolate population) remains
in the same chromosomal location defined 14 years ago [47]. This,
together with the observation that tcdB-RBD and tcdC sequences are
largely congruent with clade, may indicate that the PaLoc inserted
into the genome once, prior to the divergence of the clades.
Subsequent homologous recombination may have imported the
divergent tcdB sequences found in clade 2 from another Clostridial
species possibly on more than one occasion. Consistent with this, the
tcdB of C. difficile strain 8864 is divergent throughout its length
(GenBank AJ011301; [52]) and is closely related to both the tcdB-
RBD found in ST-1 (027), and the tcdB N-terminal catalytic domain
of ST-37 (017, A-B+, clade 4) [53]. TcdB sequences are therefore
either 8864-like or CD630-like (ST-54, clade 1, [51]), or mosaics of
the two. An alternative explanation for the observed congruence of
clade and PaLoc is that the PaLoc inserts in a nucleotide sequence
and lineage specific manner, possibly in the form of a clade-specific
bacteriophage. The latter is supported by the occurrence of non-
toxigenic STs throughout clade 1, and in clade 4 (Fig. 1). Three STs
had both toxigenic and non-toxigenic variants (Fig. 1). Interestingly,
the eBURST diagram (Fig. 1B) [45] showed that the three STs (ST-
3, ST-7, and ST-48) identified in both toxigenic and non-toxigenic
form were single locus variants clustering closely together. This may
indicate PaLoc instability within a common genetic background.
Putative hypervirulence features of the ST-1 (027) PaLoc
(relating to increased toxin production) [18,24,30,31,33,34] were
not exclusive to this genotype. The divergent tcdB-RBD sequence
occurred throughout clade 2 (Fig. 3) and two clade 2 ST-41
isolates had the same tcdC truncation as ST-1 (Fig. 4). However,
the very low incidence of these isolates (Table 1) suggests they
differ from ST-1 in transmissibility and/or other determinants of
pathogenicity.
The tcdB-RBD and tcdC loci of clade 5 ST-11 (078) were closely
related to clades 1 to 4 (Fig. 3 and Fig. 4), in contrast to its MLST
loci which were divergent from the other clades (Fig. 1).
Furthermore, the PaLoc tcdC of clade 3 and clade 5 ST-11 (078)
uniquely shared the same nucleotide substitution that truncates the
protein. This raises the possibility that clade 3 may, (like clade 5
hypervirulent ST-11 078) have high virulence potential, a
hypothesis that will be tested using clinical severity data collected
for these isolates. Clade 3 is associated with CDI, causing 49 cases
during the study (3.8%), compared to 27 (2.1%) cases due to ST-
11 (078). National surveillance data for England show that clade 3
associated PCR-ribotype 023 was endemic in the South during
this study period [17], the incidence peaking at ,18% (London
region, April to June 2007). PCR-ribotype 023 represented 43 of
2030 (2.1%) UK isolates collected during the 1990s [54] and has
been detected in Poland and Finland [55,56].
Truncation of TcdC occurred by two different mechanisms; a
single nucleotide deletion (in some clade 2 isolates) and a single
nucleotide substitution (common to all members of clades 3 and 5)
(Fig. 4). The evolution of this truncation at least twice may indicate
evolutionary convergence due to a common selective advantage.
These three clades are associated with clinically more severe
disease relative to clades 1 and 4 (data not shown).
Three STs in clade 1 (ST-9, ST-10 and ST-51) are of interest as
they occur with both wild type tcdC, and a coiled-coil domain D18
(Fig. 4, Table 1). This deletion did not impact on tcdC function in a
tcdA-b-glucuronidase reporter fusion constructed in C. perfringens
[14]. The naturally occurring paired D18tcdC and wild type tcdC
variants we describe could be used to confirm these observations.
Our mutants harboured the D18 nt in two different locations,
suggesting the nucleotide repeats of the coiled-coil domain are
unstable, with the 18 nt deletion arising more than once (Fig. 4).
We intend to test the hypothesis that specific STs and, or PaLoc
variants are associated with more or less severe disease, using
clinical data collected for this large cohort of CDI cases. Data on
the relative pathogenicity of different genotypes would assist
patient management, targeting of infection control resources and
the identification of emergent hypervirulent strains. This large
data set provides a framework for further study of C. difficile
population biology, and establishes a baseline against which
isolates from different hosts and geographic regions can be
compared, to understand the sources and evolutionary origins of
C. difficile strains that currently cause infection in humans.
Materials and Methods
Ethics Statement
This study focused only on characterising C. difficile isolates that
were archived on an ongoing basis. As this study did not use any
patient data, the research ethics committee advised that ethical
approval was not required.
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Isolates
All sequential C. difficile positive stool samples identified by
enzyme immunoassay (EIA) (Premier Toxins A&B Enzyme
Immunoassay; Meridian Bioscience Europe, Italy) at the Clinical
Microbiology Laboratory, Oxford Radcliffe Hospitals NHS Trust,
Oxford, UK, between September 2006 and December 2009 were
targeted for inclusion in this study. Approximately 70% of EIA
positive stools from September 2006 to August 2007, and
approximately 95% from September 2007 to December 2009
were retained, and contained sufficient faecal sample for culture,
performed as in [22]. The routinely submitted faecal samples were
obtained from both hospital and community patients. The size of
the population served is approximately 600,000, which represents
around 1% of the UK population. When more than one faecal
sample received from a single patient yielded isolates of the same
genotype, only the first isolate was included. A total of 1290
isolates were available for study, representing 1217 patients and
1277 episodes of diarrhoea (based on a 14 day de-duplication).
Genotyping
MLST and PCR-ribotyping were performed as described
previously [22]. The composition of all PCRs was as before, [22]
with additional oligonucleotide primers as follows. Absence of the
PaLoc was confirmed using PCR primer pair lok1 and lok3 [22,42]
(Fig. 2). The tcdB-RBD fragment was amplified and sequenced using
oligonucleotide primer pair tcdB3 59-GTAGTTGGATGGAAR-
GATTTAG-39 and tcdB4 59-CATCYAAAGTATTTTGAT-
GTGC-39 (712bp amplicon). Amplification conditions were 95uC
for 15s, followed by 35 cycles of 94uC for 30 s, 50uC for 40 s, and
72uC for 1 min 10 s, then 72uC for 5 min. The tcdC sequence was
amplified and sequenced using primer pair tcdC-F1 59 AATTTT-
TAGTCAACTAGTTATTTTAAG-39 (located 75 nt upstream of
the tcdC initiation codon) tcdC-R1 59-TATAGTTCCAGCACT-
TATACCTC-39 (688 bp amplicon). Amplification conditions were
95uC for 15s, followed by 35 cycles of 94uC for 30 s, 59uC for 30 s,
and 72uC for 1 min, then 72uC for 5 min. High throughput
nucleotide sequencing was performed as described [22]. MLST or
tcdB-RBD and tcdC sequencing of all the isolates giving a newly
identified allelic profile (ST) or allele nucleotide sequence was
performed at least twice, each time using newly extracted DNA
from the isolate to confirm the result.
Phylogenetic Analysis
Manual alignments of nucleotide sequences containing deletions
were prepared using BioEdit Sequence Alignment Editor [57], and
using the program ClustalW2 (http://www.ebi.ac.uk/Tools/
clustalw2/index.html). Neighbour joining trees were constructed
using MEGA version 4 (available from http://www.megasoftware.
net/) [58]. Phylogenetic networks were constructed using
Neighbour-Net (part of the SplitsTree4 software package,
http://www.splitstree.org) [59]. eBURST [45] was used to
investigate relationship among STs on the basis of alleleic profiles.
ClonalFrame analysis [46] was performed by preparing an
extended multi-FASTA file containing one representative of each
of the 78 STs. ClonalFrame reconstructs genealogies in a similar
fashion to traditional phylogenetic techniques, with the difference
that it detects, quantifies and accounts for the effect of homologous
recombination. ClonalFrame was run for 100,000 iterations, the
first half of which was discarded to allow for convergence.
Convergence and mixing were found to be suitable by comparison
of four independent runs.
Supporting Information
Figure S1 Clonal population structure is supported by
clustering of STs sharing the same ribotype. ClonalFrame
analysis of all 78 STs as shown in Fig. 1C. PCR-ribotypes which
occurred with more than one ST (Table S3) are mapped onto the
tree and given a unique colour.
(TIF)
Table S1 Frequency of different STs within the clinical
isolate dataset (n=1290), ranked in descending order of
abundance. The clade of each ST is indicated, followed by the
number of non-toxigenic isolates of each ST, and the frequency of
the different tcdB and tcdC alleles associated with toxigenic variants
of each ST. N/A: not applicable as all isolates of this ST were non-
toxigenic.
(DOC)
Table S2 dN/dS values for MLST and PaLoc loci.
(XLS)
Table S3 Association of PCR-ribotype and ST. A total of
285 isolates were PCR-ribotyped; 242 isolates during the study
and 43 isolates previously [22]. STs occurring with more than one
PCR-ribotype and PCR-ribotypes occurring with more than one
ST are shown in the table. The following PCR-ribotypes occurred
with one ST (.1 isolate typed): 027-ST1 (n = 46), 002-ST8
(n = 12), 078-ST11 (n = 6), 018-ST17 (n = 6), 026-ST7 (n = 4), 081-
ST9 (n = 4), 137-ST4 (n = 4), 017-ST37 (n = 3), 012-ST54 (n = 2).
The following PCR-ribotypes occurred with one ST (1 isolate
typed): 070-ST55, 129-ST13, 046-ST35, 216-ST33, 320-ST46,
010-ST15, 053-ST63, 054-ST43, 022-ST66, 316-ST59, 062-
ST75, 097-ST21, 019-ST67, 319-ST74, 139-ST52, 110-ST19,
202-ST24, 140-ST26, 228-ST92, 326-ST91, 323-ST31, 138-
ST23.
(XLSX)
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